Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 731

1.

Detection of HIV transmission hotspots in British Columbia, Canada: A novel framework for the prioritization and allocation of treatment and prevention resources.

McLaughlin A, Sereda P, Oliveira N, Barrios R, Brumme CJ, Brumme ZL, Montaner JSG, Joy JB.

EBioMedicine. 2019 Oct;48:405-413. doi: 10.1016/j.ebiom.2019.09.026. Epub 2019 Oct 15.

2.

Risk of myocardial infarction among people living with HIV: an updated systematic review and meta-analysis.

Eyawo O, Brockman G, Goldsmith CH, Hull MW, Lear SA, Bennett M, Guillemi S, Franco-Villalobos C, Adam A, Mills EJ, Montaner JSG, Hogg RS.

BMJ Open. 2019 Sep 24;9(9):e025874. doi: 10.1136/bmjopen-2018-025874.

3.

The potential impact of initiating antiretroviral therapy with integrase inhibitors on HIV transmission risk in British Columbia, Canada.

Zhu J, Rozada I, David J, Moore DM, Guillemi SA, Barrios R, Montaner JSG, Lima VD.

EClinicalMedicine. 2019 Jul 10;13:101-111. doi: 10.1016/j.eclinm.2019.07.001. eCollection 2019 Aug.

4.

Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada.

Enns B, Min JE, Panagiotoglou D, Montaner JSG, Nosyk B; STOP HIV/AIDS study group.

BMC Health Serv Res. 2019 Sep 3;19(1):626. doi: 10.1186/s12913-019-4391-8.

5.

The syndemic effect of HIV/HCV co-infection and mental health disorders on acute care hospitalization rate among people living with HIV/AIDS: a population-based retrospective cohort study.

St-Jean M, Tafessu H, Closson K, Patterson TL, Lavergne MR, Elefante J, Ti L, Hull MW, Hogg RS, Barrios R, Shoveller JA, Montaner JSG, Lima VD.

Can J Public Health. 2019 Aug 22. doi: 10.17269/s41997-019-00253-w. [Epub ahead of print]

PMID:
31441005
6.

Incidence of select chronic comorbidities among a population-based cohort of HIV-positive individuals receiving highly active antiretroviral therapy.

Gali B, Eyawo O, Hull MW, Samji H, Zhang W, Sereda P, Lima VD, McGrail K, Montaner JSG, Hogg RS, Moore D; COAST Study Team.

Curr Med Res Opin. 2019 Nov;35(11):1955-1963. doi: 10.1080/03007995.2019.1645999. Epub 2019 Aug 26.

PMID:
31315470
7.

HIV, schizophrenia, and all-cause mortality: A population-based cohort study of individuals accessing universal medical care from 1998 to 2012 in British Columbia, Canada.

Closson K, McLinden T, Patterson TL, Eyawo O, Kibel M, Card KG, Salters K, Chau W, Ye M, Hull MW, Lima VD, Montaner JSG, Hogg RS; Comparative Outcomes And Service Utilization Trends (COAST) Study.

Schizophr Res. 2019 Jul;209:198-205. doi: 10.1016/j.schres.2019.04.020. Epub 2019 Jun 27.

PMID:
31255392
8.

Structural Design and Data Requirements for Simulation Modelling in HIV/AIDS: A Narrative Review.

Zang X, Krebs E, Wang L, Marshall BDL, Granich R, Schackman BR, Montaner JSG, Nosyk B; Localized HIV modeling study group.

Pharmacoeconomics. 2019 Oct;37(10):1219-1239. doi: 10.1007/s40273-019-00817-1. Review.

PMID:
31222521
9.

Overrepresentation of Injection Drug Use Route of Infection Among Human Immunodeficiency Virus Long-term Nonprogressors: A Nationwide, Retrospective Cohort Study in China, 1989-2016.

Han J, Wu Z, McGoogan JM, Mao Y, Tang H, Li J, Zhao Y, Jin C, Detels R, Brookmeyer R, Lima VD, Montaner JSG.

Open Forum Infect Dis. 2019 Apr 8;6(5):ofz182. doi: 10.1093/ofid/ofz182. eCollection 2019 May.

10.

Retention in care and mortality trends among patients receiving comprehensive care for HIV infection: a retrospective cohort study.

Ulloa AC, Puskas C, Yip B, Zhang W, Stanley C, Stone S, Pedromingo M, Lima VD, Montaner JSG, Guillemi S, Barrios R.

CMAJ Open. 2019 Apr 12;7(2):E236-E245. doi: 10.9778/cmajo.20180136. Print 2019 Apr-Jun.

11.

Physicians' patient base composition and mortality among people living with HIV who initiated antiretroviral therapy in a universal care setting.

Allan B, Closson K, Collins AB, Kibel M, Pan S, Cui Z, McLinden T, Parashar S, Lima VD, Chia J, Yip B, Barrios R, Montaner JSG, Hogg RS.

BMJ Open. 2019 Mar 20;9(3):e023957. doi: 10.1136/bmjopen-2018-023957.

12.

Missed opportunities for earlier diagnosis of HIV in British Columbia, Canada: A retrospective cohort study.

Nanditha NGA, St-Jean M, Tafessu H, Guillemi SA, Hull MW, Lu M, Henry B, Barrios R, Montaner JSG, Lima VD.

PLoS One. 2019 Mar 21;14(3):e0214012. doi: 10.1371/journal.pone.0214012. eCollection 2019.

13.

Predicting Virological Response to HIV Treatment Over Time: A Tool for Settings With Different Definitions of Virological Response.

Revell AD, Wang D, Perez-Elias MJ, Wood R, Tempelman H, Clotet B, Reiss P, van Sighem AI, Alvarez-Uria G, Nelson M, Montaner JSG, Lane HC, Larder BA.

J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):207-215. doi: 10.1097/QAI.0000000000001989.

PMID:
30865186
14.

Why Maximizing Quality-Adjusted Life Years, rather than Reducing HIV Incidence, Must Remain Our Objective in Addressing the HIV/AIDS Epidemic.

Nosyk B, Min JE, Zang X, Feaster DJ, Metsch L, Marshall BDL, Rio CD, Granich R, Schackman BR, Montaner JSG.

J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958218821962. doi: 10.1177/2325958218821962.

15.

Correction: Disparities in the Burden of HIV/AIDS in Canada.

Hogg RS, Heath K, Lima VD, Nosyk B, Kanters S, Wood E, Kerr T, Montaner JSG.

PLoS One. 2018 Dec 6;13(12):e0209045. doi: 10.1371/journal.pone.0209045. eCollection 2018.

16.

ASSESSING THE RELATIONSHIP BETWEEN PHYSICIAN AVAILABILITY AND VIRAL LOAD SUPPRESSION IN BRITISH COLUMBIA.

Amram O, Wang L, Sereda P, Shoveller JA, Barrios R, Montaner JSG, Lima VD.

Can Geogr. 2018 Summer;62(2):120-129. doi: 10.1111/cag.12433. Epub 2017 Dec 24.

17.

Factors associated with delayed and late ART initiation among people living with HIV in BC: results from the engage study.

Kesselring S, Osborne C, Bever A, Salters K, Cui Z, Chia J, Moore DM, Parashar S, Kaida A, Samji H, Duddy J, Gabler K, Howard T, Nash D, McCandless LC, Patterson TL, Corneil T, Montaner JSG, Hogg RS.

AIDS Care. 2019 Jul;31(7):885-892. doi: 10.1080/09540121.2018.1549722. Epub 2018 Nov 22.

PMID:
30466303
18.

A systematic review of the geospatial barriers to antiretroviral initiation, adherence and viral suppression among people living with HIV.

Card KG, Lachowsky NJ, Althoff KN, Schafer K, Hogg RS, Montaner JSG.

Sex Health. 2019 Feb;16(1):1-17. doi: 10.1071/SH18104.

PMID:
30409243
19.

Prevalence and Correlates of Reporting Difficulty Taking Antiretroviral Treatment Among HIV-Positive Illicit Drug Users in Vancouver, Canada: A Longitudinal Analysis.

Yeung B, Mohd Salleh NA, Socías E, Dong H, Shoveller J, Montaner JSG, Milloy MS.

AIDS Behav. 2019 May;23(5):1250-1257. doi: 10.1007/s10461-018-2271-6.

PMID:
30284081
20.

Expert consensus statement on the science of HIV in the context of criminal law.

Barré-Sinoussi F, Abdool Karim SS, Albert J, Bekker LG, Beyrer C, Cahn P, Calmy A, Grinsztejn B, Grulich A, Kamarulzaman A, Kumarasamy N, Loutfy MR, El Filali KM, Mboup S, Montaner JS, Munderi P, Pokrovsky V, Vandamme AM, Young B, Godfrey-Faussett P.

J Int AIDS Soc. 2018 Jul;21(7):e25161. doi: 10.1002/jia2.25161.

21.

Decreased telomere length in the small airway epithelium suggests accelerated aging in the lungs of persons living with human immunodeficiency virus (HIV).

Xu S, Vucic EA, Shaipanich T, Lam S, Lam W, Montaner JS, Sin DD, Paul Man SF, Leung JM.

Respir Res. 2018 Jun 13;19(1):117. doi: 10.1186/s12931-018-0821-0.

22.

2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings.

Revell AD, Wang D, Perez-Elias MJ, Wood R, Cogill D, Tempelman H, Hamers RL, Reiss P, van Sighem AI, Rehm CA, Pozniak A, Montaner JSG, Lane HC, Larder BA; RDI Data and Study Group.

J Antimicrob Chemother. 2018 Aug 1;73(8):2186-2196. doi: 10.1093/jac/dky179.

23.

Nationwide Cohort Study of Antiretroviral Therapy Timing: Treatment Dropout and Virological Failure in China, 2011-2015.

Zhao Y, Wu Z, McGoogan JM, Sha Y, Zhao D, Ma Y, Brookmeyer R, Detels R, Montaner JSG.

Clin Infect Dis. 2019 Jan 1;68(1):43-50. doi: 10.1093/cid/ciy400.

24.

The impact of HCV co-infection status on healthcare-related utilization among people living with HIV in British Columbia, Canada: a retrospective cohort study.

Ma H, Villalobos CF, St-Jean M, Eyawo O, Lavergne MR, Ti L, Hull MW, Yip B, Wu L, Hogg RS, Barrios R, Shoveller JA, Montaner JSG, Lima VD.

BMC Health Serv Res. 2018 May 2;18(1):319. doi: 10.1186/s12913-018-3119-5.

25.

Adverse drug reactions to integrase strand transfer inhibitors.

Lepik KJ, Yip B, Ulloa AC, Wang L, Toy J, Akagi L, Lima VD, Guillemi S, Montaner JSG, Barrios R.

AIDS. 2018 Apr 24;32(7):903-912. doi: 10.1097/QAD.0000000000001781.

PMID:
29424784
26.

Social and structural factors associated with greater time with a plasma HIV-1 RNA viral load above log10(1500) copies/ml among illicit drug users.

Kennedy MC, Kerr TH, Wood E, Shoveller JA, Montaner JSG, Milloy MS.

AIDS. 2018 May 15;32(8):1059-1067. doi: 10.1097/QAD.0000000000001777.

27.

Mortality among people living with HIV/AIDS with non-small-cell lung cancer in the modern HAART Era.

Smith DM, Salters KA, Eyawo O, Franco-Villalobos C, Jabbari S, Wiseman SM, Press N, Montaner JSG, Man SFP, Hull M, Hogg RS.

AIDS Care. 2018 Jul;30(7):936-942. doi: 10.1080/09540121.2018.1434120. Epub 2018 Feb 7.

PMID:
29411625
28.

Trends in discharges from the HIV/AIDS ward at a tertiary Canadian Hospital from 2005 to 2014.

Jaworsky D, Phillips P, Cui Z, Chau W, Colley G, Dutta R, Yip B, Kremer H, Eyawo O, Montaner JS, Hull MW.

AIDS Care. 2018 Sep;30(9):1099-1106. doi: 10.1080/09540121.2018.1434121. Epub 2018 Feb 4.

PMID:
29397766
29.

Trends in Awareness and Use of HIV PrEP Among Gay, Bisexual, and Other Men who have Sex with Men in Vancouver, Canada 2012-2016.

Mosley T, Khaketla M, Armstrong HL, Cui Z, Sereda P, Lachowsky NJ, Hull MW, Olarewaju G, Jollimore J, Edward J, Montaner JSG, Hogg RS, Roth EA, Moore DM.

AIDS Behav. 2018 Nov;22(11):3550-3565. doi: 10.1007/s10461-018-2026-4.

PMID:
29344740
30.

Cohort profile: the Comparative Outcomes And Service Utilization Trends (COAST) Study among people living with and without HIV in British Columbia, Canada.

Eyawo O, Hull MW, Salters K, Samji H, Cescon A, Sereda P, Lima VD, Nosyk B, Whitehurst DGT, Lear SA, Montaner JSG, Hogg RS; Comparative Outcomes And Service Utilization Trends (COAST) Study.

BMJ Open. 2018 Jan 13;8(1):e019115. doi: 10.1136/bmjopen-2017-019115.

31.

Declining Mortality Rates in HIV-Infected People Who Inject Drugs During a Seek-and-Treat Initiative in Vancouver, Canada, 1996-2014: A Prospective Cohort Study.

Hayashi K, Dong H, Kerr T, Dobrer S, Guillemi S, Barrios R, Montaner JSG, Wood E, Milloy MJ.

J Infect Dis. 2017 Dec 27;217(1):64-68. doi: 10.1093/infdis/jix459.

32.

Incidence of diabetes mellitus and factors associated with its development in HIV-positive patients over the age of 50.

Samad F, Harris M, Puskas CM, Ye M, Chia J, Chacko S, Bondy GP, Lima VD, Montaner JS, Guillemi SA.

BMJ Open Diabetes Res Care. 2017 Nov 26;5(1):e000457. doi: 10.1136/bmjdrc-2017-000457. eCollection 2017.

33.

Progress towards the United Nations 90-90-90 and 95-95-95 targets: the experience in British Columbia, Canada.

Lima VD, St-Jean M, Rozada I, Shoveller JA, Nosyk B, Hogg RS, Sereda P, Barrios R, Montaner JSG.

J Int AIDS Soc. 2017 Nov;20(3). doi: 10.1002/jia2.25011.

34.

HIV treatment simplification to elvitegravir/cobicistat/emtricitabine/tenofovir disproxil fumarate (E/C/F/TDF) plus darunavir: a pharmacokinetic study.

Harris M, Ganase B, Watson B, Harrigan PR, Montaner JSG, Hull MW.

AIDS Res Ther. 2017 Nov 2;14(1):59. doi: 10.1186/s12981-017-0185-4.

35.

Immediate Antiretroviral Therapy Decreases Mortality Among Patients With High CD4 Counts in China: A Nationwide, Retrospective Cohort Study.

Zhao Y, Wu Z, McGoogan JM, Shi CX, Li A, Dou Z, Ma Y, Qin Q, Brookmeyer R, Detels R, Montaner JSG.

Clin Infect Dis. 2018 Feb 10;66(5):727-734. doi: 10.1093/cid/cix878.

36.

Characterizing Human Immunodeficiency Virus Antiretroviral Therapy Interruption and Resulting Disease Progression Using Population-Level Data in British Columbia, 1996-2015.

Wang L, Min JE, Zang X, Sereda P, Harrigan RP, Montaner JSG, Nosyk B.

Clin Infect Dis. 2017 Oct 16;65(9):1496-1503. doi: 10.1093/cid/cix570.

37.

The Cost-Effectiveness of Human Immunodeficiency Virus Testing and Treatment Engagement Initiatives in British Columbia, Canada: 2011-2013.

Nosyk B, Min JE, Krebs E, Zang X, Compton M, Gustafson R, Barrios R, Montaner JSG; STOP HIV/AIDS Study Group.

Clin Infect Dis. 2018 Feb 10;66(5):765-777. doi: 10.1093/cid/cix832.

38.

Belief in Treatment as Prevention and Its Relationship to HIV Status and Behavioral Risk.

Card KG, Armstrong HL, Lachowsky NJ, Cui Z, Sereda P, Carter A, Montaner JSG, Hogg RS, Roth EA, Moore DM.

J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):8-16. doi: 10.1097/QAI.0000000000001557.

39.

A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015.

Olding M, Enns B, Panagiotoglou D, Shoveller J, Harrigan PR, Barrios R, Kerr T, Montaner JSG, Nosyk B.

J Int AIDS Soc. 2017 Sep 19;20(1):21941. doi: 10.7448/IAS.20.1.21941. Review.

40.

The effect of socioeconomic disadvantage on strategies to end the AIDS epidemic.

Hogg RS, Puskas C, Parashar S, Montaner JSG.

Lancet Public Health. 2016 Nov;1(1):e6-e7. doi: 10.1016/S2468-2667(16)30007-X. Epub 2016 Oct 12. No abstract available.

41.

Testing and linkage to HIV care in China: a cluster-randomised trial.

Wu Z, Tang Z, Mao Y, Van Veldhuisen P, Ling W, Liu D, Shen Z, Detels R, Lan G, Erinoff L, Lindblad R, Gu D, Tang H, Hu L, Zhu Q, Lu L, Oden N, Hasson AL, Zhao Y, McGoogan JM, Ge X, Zhang N, Rou K, Zhu J, Wei H, Shi CX, Jin X, Li J, Montaner JSG.

Lancet HIV. 2017 Dec;4(12):e555-e565. doi: 10.1016/S2352-3018(17)30131-5. Epub 2017 Aug 31.

42.

Association between public injecting and drug-related harm among HIV-positive people who use injection drugs in a Canadian setting: A longitudinal analysis.

Ickowicz S, Wood E, Dong H, Nguyen P, Small W, Kerr T, Montaner JSG, Milloy MJ.

Drug Alcohol Depend. 2017 Nov 1;180:33-38. doi: 10.1016/j.drugalcdep.2017.07.016. Epub 2017 Aug 10.

43.

Factors associated with low neighborhood cohesion among women living with HIV impacted by social-structural inequities in British Columbia.

Closson K, Palmer AK, Collins AB, Salters K, Zhang W, Montaner JSG, Hogg RS, Parashar S.

AIDS Care. 2018 Mar;30(3):318-324. doi: 10.1080/09540121.2017.1363368. Epub 2017 Aug 17.

PMID:
28814104
44.

Erratum to: Factors Associated with Mood Disorder Diagnosis Among a Population Based Cohort of Men and Women Living With and Without HIV in British Columbia Between 1998 and 2012.

Closson K, Osborne C, Smith DM, Kesselring S, Eyawo O, Card K, Sereda P, Jabbari S, Franco-Villalobos C, Ahmed T, Gabler K, Patterson T, Hull M, Montaner JSG, Hogg RS; Comparative Outcomes and Services utilization Trends (COAST) study.

AIDS Behav. 2018 May;22(5):1541. doi: 10.1007/s10461-017-1858-7. No abstract available.

PMID:
28741132
45.

Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach.

Jacka B, Bray BC, Applegate TL, Marshall BDL, Lima VD, Hayashi K, DeBeck K, Raghwani J, Harrigan PR, Krajden M, Montaner JSG, Grebely J Senior.

J Viral Hepat. 2018 Jan;25(1):28-36. doi: 10.1111/jvh.12758. Epub 2017 Sep 4.

46.

Informing Targeted Interventions to Optimize the Cascade of HIV Care Using Cluster Analyses of Health Resource Use Among People Living with HIV/AIDS.

Krebs E, Min JE, Bayoumi AM, Barrios R, Montaner JSG, Nosyk B; STOP HIV/AIDS Study Group.

AIDS Behav. 2018 Jan;22(1):234-244. doi: 10.1007/s10461-017-1839-x.

47.

Increased mortality among Indigenous persons in a multisite cohort of people living with HIV in Canada.

Benoit AC, Younger J, Beaver K, Jackson R, Loutfy M, Masching R, Nobis T, Nowgesic E, O'Brien-Teengs D, Whitebird W, Zoccole A, Hull M, Jaworsky D, Benson E, Rachlis A, Rourke SB, Burchell AN, Cooper C, Hogg RS, Klein MB, Machouf N, Montaner JSG, Tsoukas C, Raboud J.

Can J Public Health. 2017 Jun 16;108(2):e169-e175. doi: 10.17269/cjph.108.5708.

PMID:
28621653
48.

Factors Associated with Mood Disorder Diagnosis Among a Population Based Cohort of Men and Women Living With and Without HIV in British Columbia Between 1998 and 2012.

Closson K, Osborne C, Smith DM, Kesselring S, Eyawo O, Card K, Sereda P, Jabbari S, Franco-Villalobos C, Ahmed T, Gabler K, Patterson T, Hull M, Montaner JSG, Hogg RS; Comparative Outcomes and Services utilization Trends (COAST) study.

AIDS Behav. 2018 May;22(5):1530-1540. doi: 10.1007/s10461-017-1825-3. Erratum in: AIDS Behav. 2017 Jul 24;:.

PMID:
28612214
49.

Care cascade structural intervention versus standard of care in the diagnosis and treatment of HIV in China: a cluster-randomized controlled trial protocol.

Mao Y, Wu Z, McGoogan JM, Liu D, Gu D, Erinoff L, Ling W, VanVeldhuisen P, Detels R, Hasson AL, Lindblad R, Montaner JSG, Tang Z, Zhao Y.

BMC Health Serv Res. 2017 Jun 12;17(1):397. doi: 10.1186/s12913-017-2323-z.

50.

Initiating HCV treatment with direct acting agents in opioid agonist treatment: When to start for people co-infected with HIV?

Panagiotoglou D, Krebs E, Min JE, Olding M, Ahamad K, Ti L, Montaner JSG, Nosyk B.

Int J Drug Policy. 2017 Sep;47:169-176. doi: 10.1016/j.drugpo.2017.05.021. Epub 2017 Jun 1.

Supplemental Content

Loading ...
Support Center